Andrew H. Tsoi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Andrew H. Tsoi has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Afia Iqbal
Department of Gastroenterology, Northern Health, Epping, Victoria, Australia
1 shared publication- Ahthavan Narendren
Department of Cardiology, Northern Health, Epping, Vic, Australia; Department of Cardiology, Austin Health, Heidelberg, Vic, Australia
1 shared publication Anand Murugasu
Department of Anatomical Pathology Royal Melbourne Hospital Parkville VIC Australia
1 shared publication- Andrew Huynh
Liver Transplant Unit, Austin Hospital, Heidelberg, VIC 3084, Australia
1 shared publication - Andy Kim Ho Lim
Department of General Medicine Monash Health Melbourne Victoria Australia
1 shared publication - Ashley Bloom
Liver Transplant Unit, Austin Hospital, Heidelberg, VIC 3084, Australia
1 shared publication
Latest Publications
- 1 March 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (3) , e2-e3
Peptic Ulcer Disease: An Unusual Presentation of a Common Problem
- 1 March 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (3) , e2-e3
Peptic Ulcer Disease: An Unusual Presentation of a Common Problem
- Open Access
- 1 December 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5680
Epidemiology and Prognostic Significance of Rapid Response System Activation in Patients Undergoing Liver Transplantation
Patients undergoing liver transplantation have a high risk of perioperative clinical deterioration. The Rapid Response System is an intensive care unit-based approach for the early recognition and management of hospitalized patients identified as high-risk for clinical deterioration by a medical emergency team (MET). The etiology and prognostic significance of clinical deterioration events is poorly understood in liver transplant patients. We conducted a cohort study of 381 consecutive adult liver transplant recipients from a prospectively collected transplant database (2011–2017). Medical records identified patients who received MET activation pre- and post-transplantation. MET activation was recorded in 131 (34%) patients, with 266 MET activations in total. The commonest triggers for MET activation were tachypnea and hypotension pre-transplantation, and tachycardia post-transplantation. In multivariable analysis, female sex, increasing Model for End-Stage Liver Disease score and hepatorenal syndrome were independently associated with MET activation. The unplanned intensive care unit admission rate following MET activation was 24.1%. Inpatient mortality was 4.2% and did not differ by MET activation status; however, patients requiring MET activation had significantly longer intensive care unit and hospital length of stay and were more likely to require inpatient rehabilitation. In conclusion, liver transplant patients with perioperative complications requiring MET activation represent a high-risk group with increased morbidity and length of stay.
- 1 December 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5680
Open AccessEpidemiology and Prognostic Significance of Rapid Response System Activation in Patients Undergoing Liver Transplantation
Patients undergoing liver transplantation have a high risk of perioperative clinical deterioration. The Rapid Response System is an intensive care unit-based approach for the early recognition and management of hospitalized patients identified as high-risk for clinical deterioration by a medical emergency team (MET). The etiology and prognostic significance of clinical deterioration events is poorly understood in liver transplant patients. We conducted a cohort study of 381 consecutive adult liver transplant recipients from a prospectively collected transplant database (2011–2017). Medical records identified patients who received MET activation pre- and post-transplantation. MET activation was recorded in 131 (34%) patients, with 266 MET activations in total. The commonest triggers for MET activation were tachypnea and hypotension pre-transplantation, and tachycardia post-transplantation. In multivariable analysis, female sex, increasing Model for End-Stage Liver Disease score and hepatorenal syndrome were independently associated with MET activation. The unplanned intensive care unit admission rate following MET activation was 24.1%. Inpatient mortality was 4.2% and did not differ by MET activation status; however, patients requiring MET activation had significantly longer intensive care unit and hospital length of stay and were more likely to require inpatient rehabilitation. In conclusion, liver transplant patients with perioperative complications requiring MET activation represent a high-risk group with increased morbidity and length of stay.
- Open Access
- 31 July 2021
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 54 (4) , 541-542
Letter: assessment of histological disease activity in Crohn's disease clinical trials—a step in the right direction, but further optimisation needed
LINKED CONTENT: This article is linked to Almradi et al paper. To view this article, visit https://doi.org/10.1111/apt.16248
- 31 July 2021
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 54 (4) , 541-542
Open AccessLetter: assessment of histological disease activity in Crohn's disease clinical trials—a step in the right direction, but further optimisation needed
LINKED CONTENT: This article is linked to Almradi et al paper. To view this article, visit https://doi.org/10.1111/apt.16248